PL1731138T3 - Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania - Google Patents

Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania

Info

Publication number
PL1731138T3
PL1731138T3 PL05727436.7T PL05727436T PL1731138T3 PL 1731138 T3 PL1731138 T3 PL 1731138T3 PL 05727436 T PL05727436 T PL 05727436T PL 1731138 T3 PL1731138 T3 PL 1731138T3
Authority
PL
Poland
Prior art keywords
producing
same
sparingly soluble
soluble drug
fine dispersion
Prior art date
Application number
PL05727436.7T
Other languages
English (en)
Inventor
Yoshiko Kubo
Tetsumi Yamakawa
Yasuomi Yamasaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL1731138T3 publication Critical patent/PL1731138T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL05727436.7T 2004-03-31 2005-03-28 Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania PL1731138T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004102780 2004-03-31

Publications (1)

Publication Number Publication Date
PL1731138T3 true PL1731138T3 (pl) 2016-10-31

Family

ID=35063485

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05727436.7T PL1731138T3 (pl) 2004-03-31 2005-03-28 Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania

Country Status (9)

Country Link
EP (1) EP1731138B1 (pl)
JP (1) JP4875979B2 (pl)
CY (1) CY1118548T1 (pl)
DK (1) DK1731138T3 (pl)
ES (1) ES2566486T3 (pl)
HU (1) HUE028288T2 (pl)
PL (1) PL1731138T3 (pl)
SI (1) SI1731138T1 (pl)
WO (1) WO2005094788A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778965B2 (en) 2005-08-01 2014-07-15 Maruho Co., Ltd. Lotion preparation containing pyridonecarboxylic acid derivative
CN1931159B (zh) * 2005-09-16 2010-05-12 天津药物研究院 艾拉莫德微粉化及口服速释制剂
CN101375834B (zh) * 2007-09-02 2012-07-04 杨喜鸿 艾拉莫德的固体分散体及其制备方法和药物应用
JP5428058B2 (ja) * 2007-12-28 2014-02-26 ライオン株式会社 微粒化エラグ酸化合物の製造方法
EP2177214A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Solid Oral Dosage Forms and Uses
EP2177208A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
EP2177209A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Intravenous solutions and uses
PL2556063T3 (pl) 2010-04-06 2015-12-31 Ferrer Int Sole kwasu 1-cyklopropylo-8-metylo-7-[5-metylo-6-(metyloamino)-3-pirydynylo]-4-okso-1,4-dihydro-3-chinolinokarboksylowego
PT105058B (pt) * 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
CN103110578B (zh) * 2013-02-05 2014-11-12 广东华南药业集团有限公司 一种灯盏花素磷脂复合物自微乳组合物及其制备方法
JP5799061B2 (ja) * 2013-08-23 2015-10-21 富山化学工業株式会社 トスフロキサシンおよびポリビニルピロリドンを含有する粒状固形製剤
JP5799062B2 (ja) * 2013-08-23 2015-10-21 富山化学工業株式会社 トスフロキサシンを含有する粒状固形製剤
JP2015166387A (ja) * 2015-06-08 2015-09-24 フエルレル インターナショナル，ソシエダッド アノニマ １‐シクロプロピル‐８‐メチル‐７‐［５‐メチル‐６‐（メチルアミノ）‐３‐ピリジニル］‐４‐オキソ‐１，４‐ジヒドロ‐３‐キノリンカルボン酸塩

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
JP2554784B2 (ja) * 1991-03-15 1996-11-13 杏林製薬株式会社 懸濁シロップ剤
US5298262A (en) * 1992-12-04 1994-03-29 Sterling Winthrop Inc. Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
US5510118A (en) * 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
IL140276A0 (en) * 1998-06-19 2002-02-10 Rtp Pharma Inc Processes to generate submicron particles of water-insoluble compounds
JP2003026676A (ja) * 2000-12-11 2003-01-29 Takeda Chem Ind Ltd 吸収性が改善された医薬組成物
DK1347747T3 (da) * 2000-12-22 2006-04-10 Baxter Int Fremgangsmåde til behandling af submikropartikelsuspensioner af farmaceutiske midler
AU2003261167A1 (en) * 2002-07-16 2004-02-02 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents

Also Published As

Publication number Publication date
EP1731138B1 (en) 2016-03-23
EP1731138A4 (en) 2012-04-25
DK1731138T3 (en) 2016-06-06
JP4875979B2 (ja) 2012-02-15
EP1731138A1 (en) 2006-12-13
JPWO2005094788A1 (ja) 2008-02-14
ES2566486T3 (es) 2016-04-13
CY1118548T1 (el) 2017-07-12
WO2005094788A1 (ja) 2005-10-13
SI1731138T1 (sl) 2016-06-30
HUE028288T2 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
PL1731138T3 (pl) Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania
IL286802A (en) Soluble glycosaminoglycan and methods for preparing and using soluble glycosaminoglycan
IL191984A0 (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
IL183583A (en) Quinazoline History and Pharmaceuticals Containing Them and Methods of Manufacturing
AU2003242988A1 (en) Process for the preparation of the anti-cancer drug imatinib and its analogues
EP1783096A4 (en) ALPHA-SIALON POWDER AND PROCESS FOR PRODUCING THE SAME
EP1971372A4 (en) COMPOSITIONS OF HYDROPHOBIC CORE CARRIERS FOR THE DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF PREPARATION AND USE
HK1105117A1 (en) Filter and production methods of the same
EP1922309A4 (en) N-PHENYL-2-PYRIMDINAMINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
IL183923A0 (en) Process for preparing voriconazole and voriconazole prepared thereby
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
IL185484A0 (en) Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
EP1884234A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASES OF CORNEAL AND BINDING SKIN
IL226403A0 (en) A process for the synthesis of mendipropamide and its history
ZA200607987B (en) Stable aqueous particle dispersion the use thereof and method for producing said dispersion
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
SI2020410T1 (sl) Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
IL175695A0 (en) Process for the preparation of valacyclovir hydrochloride
IL190771A0 (en) Compressed solid dosage forms with drugs of low solubility and process for making the same
HK1102395A1 (en) Indene derivatives and process for the preparation thereof
EP1782821A4 (en) MEDICAMENT AND METHOD FOR IMPROVING BRAIN FUNCTION
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
EP1756036A4 (en) INDENED DERIVATIVES AND PROCESS FOR THEIR PREPARATION
IL185205A0 (en) Amide derivatives as ion-channel ligands and pharmaceutical composition and methods of using the same